| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3914efe47c8572b94fe0876c2c6cf74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbe675b46d686407d64e31a937562663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_304ad027c6e2938dd22c98fa7c9534bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d888accfa017bf14ed602e63babbf17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf57853b4268c665a3a702d0acbf2dcb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5cf639d5c2d6c6bf46904f29a87d2a45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc4c09b3a5800aba594fae683f0658a6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2006-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc4060482c37188dc5d27bf4e2cb997f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b48b183e674b113e11c00154bca21209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1df8e81c996adff6af96f3374005f909
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba8c755e4d6e38d45f290b31b4102190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b3148af6c8faea0572e5babfebb4376
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76ef86ca60e23cd638b7e04c8a4fe4e5 |
| publicationDate |
2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006125513-A1 |
| titleOfInvention |
Genetic association of polymorphisms in the atf6-alpha gene with insulin resistance phenotypes |
| abstract |
The present invention relates to polymorphisms in the ATF6-alpha gene or locus which show genetic association with insulin resistance phenotypes, such as metabolic syndrome and type 2 diabetes. The present invention further relates to methods of genetic diagnosis of insulin resistance phenotypes comprising testing polymorphisms in the ATF6-alpha gene or locus and to reagents suitable for use in such methods. Further the invention relates to screening methods for compounds modulating the expression and/or function of ATF6-alpha gene and/or protein, which are useful in treatment and/or prevention of insulin resistance phenotypes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8685647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011150545-A1 |
| priorityDate |
2005-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |